Venmax Drugs Allots 21.47 Lakh Equity Shares on Warrant Conversion

Venmax Drugs and Pharmaceuticals Ltd announced the allotment of 21,47,665 equity shares following the conversion of an equal number of convertible warrants. The conversion was approved by the Board of Directors on July 29, 2026. These warrants were initially allotted on March 20, 2025. The equity shares were issued at an issue price of ₹20 each (₹10 face value and ₹10 premium). The company received the balance exercise price of ₹15 per warrant, aggregating to ₹3,22,14,975. This allotment increases the company's paid-up capital to ₹13,73,05,950, comprising 1,37,30,595 equity shares.